Skip to content
Understanding TTP
  • Home
  • About TTP
    • Key Points
    • Introduction to TTP
    • Types of TTP
  • Understanding your diagnosis
    • Key Points
    • Diagnosing TTP
    • Understanding your platelet counts & ADAMTS13 levels
  • Treating TTP
    • Acquired TTP – Overview of acute treatment
    • Key Points
    • What to expect from TTP treatment?
    • Follow-up monitoring and treatment
    • Inherited TTP – overview of acute treatment
  • Resources
    • Support Groups
    • Newsletter
    • Videos
    • Glossary of terms

Understanding TTP in German

We’re excited to announce the launch of the German version of Understanding TTP. With the launch of this additional content in German, we hope to provide support and up to date information to a greater number of patients, caregivers and health care professionals affected by Thrombotic Thrombocytopenic Purpura (TTP).

For more information, updates on additional languages and useful links, please visit our website at www.understandingttp.com.

  • contact
  • legal notice
  • privacy policy

This site is intended for US audiences

CABLIVI is a registered trademark of Ablynx N.V., Belgium, an affiliate of Sanofi.
©2019 Sanofi Genzyme. All rights reserved. SAUS.CAPL.18.12.7206 February 2019

Now leaving Understanding TPP

You are leaving www.UnderstandingTPP.com and linking to an external site.

Ablynx provides links to other websites as a convenience. Ablynx does not endorse,
cannot control, and is not resposible for the content of any other sites.